SEC-sourced researchBeta
TMCI
TREACE MEDICAL CONCEPTS, INC.
Company comparison ↗
Data passport
- CIK
- 0001630627
- Exchange
- Nasdaq
- Business activity
- — · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 187,118,000.0000 | Feb 27, 2026 |
| December 2024 | 209,357,000.0000 | Feb 27, 2026 |
| December 2025 | 212,690,000.0000 | Feb 27, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 212,690,000.0000 | -59,002,000.0000 | -15,970,000.0000 | 190,581,000.0000 | 103,249,000.0000 | Feb 27, 2026 |
| December 2024 | 209,357,000.0000 | -55,743,000.0000 | -37,167,000.0000 | 217,094,000.0000 | 104,202,000.0000 | Feb 27, 2026 |
| December 2023 | 187,118,000.0000 | -49,527,000.0000 | -34,575,000.0000 | — | — | Feb 27, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $212.69M | December 2025 | Feb 27, 2026 | 10-K |
| Previous period revenueRevenues | $209.36M | December 2024 | Feb 27, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$59M | December 2025 | Feb 27, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$15.97M | December 2025 | Feb 27, 2026 | 10-K |
| Total assetsAssets | $190.58M | December 2025 | Feb 27, 2026 | 10-K |
| Total liabilitiesLiabilities | $103.25M | December 2025 | Feb 27, 2026 | 10-K |